000			01919nam a22002897a 4500
003			OSt
005			20240305193737.0
008			221124b |||||||| |||| 00| 0 eng d
020			_a978-1-63117-186-4
028			_b Phone: +255 28 298 3384
028			_b Fax: +255 28 298 3386
028			_b Email: vc@bugando.ac.tz
028			_b Website: www.bugando.ac.tz
040			_bEnglish _cDLC
041			_aEnglish
100			_aHyasinta Jaka _919670
222			_aLife cycle, developmental stages, intermediate hosts, definitive host, pathogenesis, interactions with other infectious diseases
245			_aThe Epidemiology, Pathogenesis, and Clinical Features of Schistosomiasis
260			_aMwanza, Tanzania: _b Nova Science Publishers, Inc. & _bCatholic University of Health and Allied Sciences [CUHAS – Bugando] _c 2014
300			_a Pages 1-208
490			_vEpidemiology, Diagnosis and Treatment
520			_aAbstract: Schistosomiasis, sometimes referred to as―bilharziasis‖, can be associated with serious morbidity and mortality. This chapter fully covers the epidemiology of the disease and the different symptoms and signs. Chronic complications are generally seen in patients with a high load of parasites. The complications usually occur in individuals who live in endemic areas and who have recurrent exposure. This chapter will also include current updates and the interaction of schistosomes with other infections since this is the area of concern to clinicians. Therefore this
700			_a Anthony Liwa _922956
700			_a Phillipo Chalya _945418
856			_uhttps://www.researchgate.net/profile/Rosimeire-De-Oliveira/publication/261562334_Epidemiology_Chemotherapy_and_New_Therapeutic_Approaches_of_Schistosomiasis/links/00b7d534b2cb0a8672000000/Epidemiology-Chemotherapy-and-New-Therapeutic-Approaches-of-Schistosomiasis.pdf#page=13
942			_2ddc _cVM
999			_c19694 _d19694